ABI
CVS icon

Adamant Biomedical Investments’s CVS Health CVS Stock Holding History

Adamant Biomedical Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$2.89M Sell
30,000
-15,000
-33% -$1.32M 0.69% 49
2014
Q3 		$3.58M Buy
+45,000
New +$3.55M 0.89% 43

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Adamant Biomedical Investments's CVS Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its CVS Health (CVS) stake by 33% in Q4 2014, selling an estimated $1.32M and leaving 30,000 shares worth $2.89M. The position accounts for 0.69% of the portfolio, ranked #49.

Adamant Biomedical Investments first reported a position in CVS in Q3 2014 and has held it in 2 quarters since. The position peaked at $3.58M in Q3 2014. 1,419 funds tracked by Wall St. Rank hold CVS as of Q4 2014.

  • Adamant Biomedical Investments held 30,000 shares of CVS Health worth $2.89M as of Q4 2014.
  • Adamant Biomedical Investments sold 15,000 CVS Health shares in Q4 2014, an estimated $1.32M.
  • CVS Health made up 0.69% of Adamant Biomedical Investments's portfolio in Q4 2014, its #49 holding.
  • Adamant Biomedical Investments first reported a position in CVS Health in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's CVS Health position peaked at $3.58M in Q3 2014.
  • 1,419 funds tracked by Wall St. Rank held CVS Health as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.